Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,521 All time
- Disclosed funding
- $64.9B 1231 disclosed amounts
- Median round
- $7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| HG HOUF GamesCompany profile HOUF Games creates board games and collectible cards built around original characters, themes and game worlds. HOUF Games creates board games and collectible cards built around original characters, themes and game worlds. | Undisclosed | Pre-seed | Media & gaming | United Kingdom | Investors | |
| B Be2ByteCompany profile Be2Byte develops LabThunder, software that helps laboratories manage equipment, maintenance records and operational knowledge. Be2Byte develops LabThunder, software that helps laboratories manage equipment, maintenance records and operational knowledge. | €500K | Seed | Enterprise software | Germany | Investors | |
| MM Model MLCompany profile Automates research, diligence and document workflows for financial institutions Automates research, diligence and document workflows for financial institutions | Undisclosed | Strategic investmentUndisclosed | Fintech | United Kingdom | Investors | |
| E ExobiosphereCompany profile Exobiosphere runs automated experiments in microgravity to help pharmaceutical and biotechnology researchers study disease and test drug candidates. Exobiosphere runs automated experiments in microgravity to help pharmaceutical and biotechnology researchers study disease and test drug candidates. | €1M | Jeune Entreprise Innovante grantUndisclosed | Biotech | Luxembourg | Investors | |
| P Builds an operating system for teams to work with AI agents across workflows | €3M | Pre-SeedPre-seed | Developer tools | Denmark | Investors | |
| VT Vaderis TherapeuticsCompany profile Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia | $152M | Series B | Biotech | Switzerland | Investors | |
| DV DR. VIVIEN KARLCompany profile DR. VIVIEN KARL is a women’s intimate-care brand selling creams, cleansing products and related personal-care items. DR. VIVIEN KARL is a women’s intimate-care brand selling creams, cleansing products and related personal-care items. | Undisclosed | Seed | Consumer | Germany | Investors | |
| AT Arab TherapyCompany profile Arab Therapy connects Arabic-speaking individuals with mental-health specialists through online sessions and digital support tools. Arab Therapy connects Arabic-speaking individuals with mental-health specialists through online sessions and digital support tools. | $2M | Pre-Series AUndisclosed | Healthtech | Germany | Investors | |
| Z ZerolookCompany profile Zerolook provides flight-search predictions that help airlines and travel platforms answer large volumes of shopping queries. Zerolook provides flight-search predictions that help airlines and travel platforms answer large volumes of shopping queries. | CHF 1.5M | Pre-seed | Travel tech | Switzerland | Investors | |
| M MatAlyticsCompany profile MatAlytics develops software that helps industrial operators assess component integrity and make operational decisions from sensor data. MatAlytics develops software that helps industrial operators assess component integrity and make operational decisions from sensor data. | £619K | Innovate UK grantUndisclosed | Industrial tech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
39rounds4led - 2Antler
Jenz, Affinity Labs, CodeWall
26rounds0led - 3Balderton Capital
Duvo, Spott, Unit1 Studio
24rounds7led - 4Index Ventures
Opply, Duvo, Spiko
22rounds3led - 5Y Combinator (YC)
HyLight, Sensible Biotechnologies, Revnu
22rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.